Edit Module

Winn Feline Foundation And Feline Pine Bring Funding To FIP Research

Posted: Tuesday, April 20, 2010, 2:17 p.m., EDT



Published:

The Winn Feline Foundation and cat litter brand Feline Pine have partnered to fund research aimed at finding a treatment for feline infectious peritonitis (FIP), a fatal disease of cats.

“We are so excited to be partnering with Feline Pine,” said Susan Little, DVM, Dipl. ABVP (feline practice), past president of the Winn Feline Foundation. “They are truly a company that cares about the life and health of cats and their support of the Winn Feline Foundation assists us in our goal to help ‘every cat, every day.’”

The research project is being led by Alfred Legendre, DVM, Dipl. ACVIM, professor in the Department of Small Animal Clinical Sciences at the University of Tennessee College of Veterinary Medicine.

FIP is believed to occur when there is a mutation of the common intestinal coronavirus. There is a depression of the cell-mediated immune response to the mutated virus, which results in an overproduction of antibodies and a loss of the cell-mediated immunity needed to destroy coronavirus-infected macrophages, according to the Winn Feline Foundation grant description. The polyprenyl immunostimulant (PI) stimulates cell-mediated immunity. The investigators will treat 20 cats diagnosed with FIP with PI.

“We look forward to a long association with the Winn Feline Foundation,” said Dan Henderson, brand manager for Feline Pine, which is based in West Palm Beach, Fla. “As a long-standing organization dedicated solely to the mission of helping the lives and welfare of all cats, the Winn Feline Foundation provides research into improving treatment of common feline health problems and helps to understand and prevent many diseases. We couldn’t be happier to be partnering with the premiere feline health research grantor in the world. We stand together in our caring and commitment to cats.”

Edit Module
Edit ModuleShow Tags

Archive »Read More

Zoetis launches Clavamox Chewable for dogs, cats

Zoetis announced the commercial launch of Clavamox Chewable (amoxicillin and clavulanate potassium tablets), which is effective in treating skin infections in dogs and cats, periodontal infections in dogs, and urinary tract infections in cats, according to the company.

​2017 National Veterinary Scholars Symposium exposes students to biomedical research

Approximately 650 veterinary students and researchers from 38 veterinary schools from the U.S., Canada, the Caribbean, the Netherlands, and France gathered Aug. 3-6 at the National Institutes of Health (NIH) to discuss innovative animal health research and the future of veterinary medicine.

Four reasons veterinary clients avoid regular checkups for their cats—and what you can do about it

A recent survey found 92 percent of cat owners say their cat’s health is important to them, but only half of all American cats taken to the veterinarian by their caretakers on a regular basis; inspire cat owners to participate in Take Your Cat to Vet Day on August 22.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module